Modelling mechanisms of resistance and predictive biomarker discovery against targeted therapy using human primary non-small cell lung cancer xenografts.
Modelling mechanisms of resistance and predictive biomarker discovery against targeted therapy using human primary non-small cell lung cancer xenografts.
使用人类原发性非小细胞肺癌异种移植物进行靶向治疗的耐药机制建模和预测性生物标志物发现。
批准号：
332338
负责人：
Stewart Erin L
金额：
$7.65万
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2014
资助国家：
加拿大
项目状态：
已结题
起止时间：
2014-10-01 至 2017-10-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Lung cancer is the leading cause of cancer related deaths; non-small cell lung cancer (NSCLC) is the predominant form of the disease. Researchers have discovered that NSCLC can be divided into groups defined by the specific molecular processes, known as "
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
